Summio

Book

Medical Device Regulation

A comprehensive practical guide to navigating FDA-CDRH medical device regulations, compliance, testing standards, and commercialization.

7 min read

Available in

Summary preview

Medical Device Regulation Companion Summary

Elijah Wreh’s reference text, Medical Device Regulation, serves as a structured guide for navigating the United States Food and Drug Administration's Center for Devices and Radiological Health (FDA-CDRH) framework. The work examines statutory definitions, regulatory policies, marketing restrictions, testing standards, design integration, and premarket application pathways.

Foundations of FDA-CDRH Regulation

The text establishes that regulatory science evolves alongside technological advancements, noting that software-driven diagnostic tools and artificial intelligence-integrated wearables shift regulatory definitions and expectations. Wreh outlines the core criteria determining whether a product falls under medical device regulations based on statutory definitions and how the FDA-CDRH categorizes products into risk-based classes: Class I, Class II, and Class III. Each classification carries progressively heavier regulatory burdens. Misclassifying a device at the outset can derail premarket pathways, making understanding these nuances essential to prevent delays and capital loss.

Market Policies and Promotional Restrictions

Regulatory policies interact directly with marketplace dynamics. Stringent premarket review requirements create barriers to entry that protect consumers from substandard products while potentially slowing the adoption of innovations, whereas streamlined pathways demand rigorous post-market surveillance to catch safety issues early. Wreh explores how policies affect business models, investor relations, and competitive positioning. Furthermore, the work details promotional boundaries set by the Federal Food, Drug, and Cosmetic Act and other federal statutes. Promotional claims must be substantiated by clinical and technical data submitted and cleared or approved during regulatory review, distinguishing permissible educational messaging from unlawful off-label promotion or unsubstantiated performance claims.